Jathin Bandari

Insider Reports History

Location
New York, NY
Signature
/s/ Mary Grendell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jathin Bandari:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protara Therapeutics, Inc. Chief Medical Officer Common Stock 56,704 $108,305 $1.91 19 Jan 2024 Direct
Protara Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 137,000 19 Jan 2024 Direct

Insider Reports Filed by Jathin Bandari

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARA Protara Therapeutics, Inc. 19 Jan 2024 3 -$5,499 4 Chief Medical Officer 23 Jan 2024, 16:05
TARA Protara Therapeutics, Inc. 10 Jan 2024 1 -$4,486 4 Chief Medical Officer 12 Jan 2024, 16:05
TARA Protara Therapeutics, Inc. 03 Jul 2023 1 -$1,678 4 Chief Medical Officer 05 Jul 2023, 16:05
TARA Protara Therapeutics, Inc. 19 Jan 2023 2 $0 4 Chief Medical Officer 20 Jan 2023, 15:00
TARA Protara Therapeutics, Inc. 10 Jan 2023 1 -$5,628 4 Chief Medical Officer 11 Jan 2023, 15:02
TARA Protara Therapeutics, Inc. 01 Jul 2022 1 -$2,196 4 Chief Medical Officer 05 Jul 2022, 17:00
TARA Protara Therapeutics, Inc. 10 Jan 2022 0 $0 4/A Chief Medical Officer 09 Mar 2022, 15:33
TARA Protara Therapeutics, Inc. 10 Jan 2022 0 $0 3 Chief Medical Officer 12 Jan 2022, 16:14